Metoprolol Succinate Tablet, Extended Release
Product Images NDC 71335-9706

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 71335-9706). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713359706)

Label (Lbl713359706)
This is a description of a medication package containing extended-release tablets of metoprolol succinate and metoprolol tartrate. Each tablet contains 95mg of the active ingredient metoprolol succinate and is equivalent to 100mg of metoprolol tartrate. The package has an NDC number of 71335-9706-1 and is child-resistant. The medication should be stored between 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). The medication is only available with a prescription and should be kept out of reach of children. The medication is repackaged by Bryant Ranch Prepack and manufactured by Vishang Humanwall.*
FDA Label Image

Picture-1 (Picture 1)

Picture-1 (Picture 1)
The text appears to be a chart presenting the results of a study called MERIT-HF that evaluated the effects of extended-release tablets on all-cause hospitalization for heart failure. The table presents the results for different subgroups based on various factors such as NYHA classification, ejection fraction, sex, race, and comorbidities, among others. The relative risk and 95% confidence interval are also given.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.